REFERENCES
- American Tort Reform Association. (2011). Punitive damages reform. http://www.atra.org/show/7343 (http://www.atra.org/show/7343) (Accessed: 8 September 2011 ).
- Campbell v. State Farm Mut. Auto. Ins. Co. 538 U.S. 408, 2003; on remand Campbll v. State Farm Mut. Auto.Ins. Co. 98 P.3d, 498 Utah Adv. Rep. 23, 2004. Cert Denied By: State Farm Mut. Auto. Ins. Co. v. Campbell, 543 U.S. 874, 2004.
- Congressional Budget Office. (2004). The effects of tort reform: Evidence from the states. 2004. http://www.cob.gov (http://www.cob.gov) (Accessed: 8 September 2011 ).
- Kesselheim , A. S. and Avorn , J. 2007 . The role of litigation in defining drug risks . JAMA , 297 : 308 – 311 .
- Mathews , A. W. and Martinez , B. November 1, 2004 2004 . “ Warning signs: E-mails suggest Merck knew Vioxx's dangers at early state—as heart risk evidence rose, officials played hardball; internal message: ‘dodge!’—company says ‘out of context.’ ” . In Wall Street J November 1, 2004 , A1
- Mundy , A. and Favole , J. 14 Jan. 2009 2009 . “ Glaxo's emails on Avandia reveal concern ” . In Wall Street J 14 Jan. 2009 ,
- U.S. Food and Drug Administration (U.S. FDA). (2011). Vioxx (rofecoxicb) Questions and Answers. http://www.fda.gov/cder/drug/infopage/vioxx/vioxxQA.htm (http://www.fda.gov/cder/drug/infopage/vioxx/vioxxQA.htm) (Accessed: 13 May 2011 ).
- Waxman , H. A. 2005 . The lessons of Vioxx—Drug safety and sales . New Engl J Med , 352 : 2576 – 2578 .